Today: 12 May 2026
IonQ Stock Surges As SkyWater Vote Clears Key Hurdle For $1.8 Billion Quantum Chip Deal

IonQ Stock Surges As SkyWater Vote Clears Key Hurdle For $1.8 Billion Quantum Chip Deal

COLLEGE PARK, Md., May 11, 2026, 12:04 EDT

IonQ surged roughly 16% Monday, beating out quantum rivals Rigetti Computing and D-Wave Quantum after SkyWater Technology investors gave the green light to IonQ’s takeover of the U.S. chip foundry. SkyWater shares added around 2.4%.

This vote edges IonQ toward handling its own semiconductor production—a shift the company argues will shore up supply for its quantum hardware ambitions. SkyWater, on its side, maintained the deal remains on track to close in either the second or third quarter, pending regulatory sign-off and other final hurdles.

Timing plays a big role for IonQ here. Quantum firms are feeling the squeeze to convert research advances into products that actually sell. Investors want to know when quantum tech will start generating steady revenue, not just rack up another technical benchmark.

According to SkyWater’s May 8 filing, roughly 32.6 million shares backed the merger proposal, with just 404,800 votes against and 92,040 abstentions. The company reported that around 67% of its outstanding shares were present at the special meeting.

Back in January, IonQ struck a deal to acquire SkyWater for roughly $1.8 billion, using a mix of cash and stock. The terms put $15 in cash and $20 in IonQ shares on the table for every SkyWater share held. If completed, SkyWater is set to operate as a wholly owned unit of IonQ, still under CEO Thomas Sonderman, according to Reuters.

Quantum computers rely on qubits—the quantum equivalent of classical computing’s bits. IonQ takes a distinct path here, building its machines around trapped ions. These charged atoms are steered by lasers and electromagnetic fields in a vacuum, setting them apart from competitors that favor other hardware setups.

Just days after shareholders gave their nod, IonQ posted first-quarter revenue of $64.7 million and bumped its 2026 revenue outlook up to a range between $260 million and $270 million. Still, the company logged an adjusted EBITDA loss of $96.8 million—a signal that significant costs remain tied to its expansion.

IonQ Chairman and CEO Niccolo de Masi pointed to “strong and growing demand” for the company’s quantum computers, noting a shift from “component-level testing to integrated, system-level testing” on its 256-qubit machine. The company’s CFO, Inder Singh, put remaining performance obligations at $470 million. IonQ Investors

The deal remains incomplete. SkyWater disclosed in an April 24 filing that the Federal Trade Commission issued a second request for details, which means the Hart-Scott-Rodino waiting period now runs until 30 days after both sides substantially comply—or until the FTC decides to wrap things up sooner, or if the parties agree to a different timeline.

The real concern right now? A drawn-out antitrust process, shaky IonQ shares, or any stumble getting the hardware up to speed—all could sway how the market sees this deal. D.A. Davidson’s Alex Platt, speaking to Reuters after IonQ posted earnings, said doubts have hung over “the viability of the technology” and IonQ’s direction with its trapped-ion qubits. Reuters

Monday’s jump shifts attention straight to IonQ’s next hurdles. Shareholders at SkyWater gave the nod, but IonQ still needs to wrap up the acquisition, integrate the foundry operation, and show that controlling more of the supply chain actually gets quantum systems to paying customers faster.

Stock Market Today

  • QuantumScape Shares Rise 11.7% on Eagle Line Launch and Initial Billings
    May 12, 2026, 5:46 PM EDT. QuantumScape (QS) gained 11.7% following the launch of its Eagle Line pilot-scale solid-state battery cell facility and initial $11 million in customer billings from ecosystem partners. The company reported a narrower GAAP net loss in Q1 2026, driven by reduced operating expenses. This marks a shift toward early commercialization and a potential licensing and royalty revenue stream, altering QuantumScape's risk profile and business model. Investors remain cautious as success depends on partner uptake and scaling production. Analysts' revenue forecasts vary widely, reflecting uncertainty around the new manufacturing blueprint. QuantumScape projects $544.5 million revenue and $33.3 million earnings by 2029, but some estimates are much lower, highlighting diverging market views.

Latest article

British American Tobacco Stock Jumps as FDA Shift Gives Vuse and Velo a Cleaner Read

British American Tobacco Stock Jumps as FDA Shift Gives Vuse and Velo a Cleaner Read

12 May 2026
British American Tobacco shares jumped 5.82% in London to £46.34 after the FDA signaled a softer enforcement stance on some e-cigarette and nicotine pouch products. A U.S. judge also dismissed BAT’s North Korea sanctions case following a $630 million settlement. The FTSE 100 slipped 0.04%. BAT’s U.S.-listed ADR closed up 5.3% at $63.64.
Camtek Stock Falls 16% After Earnings Beat as Margin Pressure and Hot CPI Hit AI Chip Trade

Camtek Stock Falls 16% After Earnings Beat as Margin Pressure and Hot CPI Hit AI Chip Trade

12 May 2026
Camtek shares fell 15.8% to $174.63 despite beating Q1 revenue and adjusted EPS estimates by small margins. Q1 revenue rose 2.5% year over year, but non-GAAP EPS dropped to $0.70 from $0.79 and operating margin narrowed to 25.5%. Management guided Q2 revenue to $129–$131 million and expects second-half revenue to rise over 25%. Broader market pressure followed a hot April CPI and rising Treasury yields.
Oscar Health stock rises in premarket after 2026 revenue outlook; House subpoenas add a fresh risk

Oscar Health Stock Extends Post-Earnings Repricing as Margins Outweigh ACA Risk

12 May 2026
Oscar Health shares rose 7.9% to $23.73 late Tuesday, with volume near 13 million, after posting strong Q1 profit and lower claims costs despite missing revenue estimates. The company’s medical loss ratio fell to 70.5% from 75.4% a year earlier. Membership climbed to 3.17 million. ACA enrollment churn and policy risk remain concerns.
Tesla Stock Rises Despite China Sales Drop as Musk’s China Trip Invitation Raises Stakes
Previous Story

Tesla Stock Rises Despite China Sales Drop as Musk’s China Trip Invitation Raises Stakes

SoFi Technologies Reported PrimaryBid Deal Could Put SOFI Stock Back in the IPO Race
Next Story

SoFi Technologies Reported PrimaryBid Deal Could Put SOFI Stock Back in the IPO Race

Go toTop